177 related articles for article (PubMed ID: 21479633)
1. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.
Wang SJ; Sun B; Cheng ZX; Zhou HX; Gao Y; Kong R; Chen H; Jiang HC; Pan SH; Xue DB; Bai XW
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1421-30. PubMed ID: 21479633
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity.
Matsuo Y; Sawai H; Ochi N; Yasuda A; Sakamoto M; Takahashi H; Funahashi H; Takeyama H; Guha S
Dig Dis Sci; 2010 Apr; 55(4):1167-76. PubMed ID: 19399612
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB.
Chen H; Sun B; Wang S; Pan S; Gao Y; Bai X; Xue D
J Cancer Res Clin Oncol; 2010 Jun; 136(6):897-903. PubMed ID: 19941148
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer.
Saito K; Matsuo Y; Imafuji H; Okubo T; Maeda Y; Sato T; Shamoto T; Tsuboi K; Morimoto M; Takahashi H; Ishiguro H; Takiguchi S
Cancer Sci; 2018 Jan; 109(1):132-140. PubMed ID: 29121426
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.
Wang SJ; Gao Y; Chen H; Kong R; Jiang HC; Pan SH; Xue DB; Bai XW; Sun B
Cancer Lett; 2010 Jul; 293(1):99-108. PubMed ID: 20137856
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway.
Chen H; Zhang J; Luo J; Lai F; Wang Z; Tong H; Lu D; Bu H; Zhang R; Lin S
Oncol Rep; 2013 Aug; 30(2):589-95. PubMed ID: 23754270
[TBL] [Abstract][Full Text] [Related]
8. Zerumbone inhibits angiogenesis by blocking NF-κB activity in pancreatic cancer.
Shamoto T; Matsuo Y; Shibata T; Tsuboi K; Nagasaki T; Takahashi H; Funahashi H; Okada Y; Takeyama H
Pancreas; 2014 Apr; 43(3):396-404. PubMed ID: 24622069
[TBL] [Abstract][Full Text] [Related]
9. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2/-9.
Rao Q; Yu H; Li R; He B; Wang Y; Guo X; Zhao G; Wu F
Fundam Clin Pharmacol; 2024 Feb; 38(1):113-125. PubMed ID: 37490927
[TBL] [Abstract][Full Text] [Related]
11. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.
Li L; Braiteh FS; Kurzrock R
Cancer; 2005 Sep; 104(6):1322-31. PubMed ID: 16092118
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.
Chen H; Sun B; Pan S; Jiang H; Sun X
Anticancer Drugs; 2009 Feb; 20(2):131-40. PubMed ID: 19209030
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y
Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
15. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
19. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Fujiwara Y; Furukawa K; Haruki K; Shimada Y; Iida T; Shiba H; Uwagawa T; Ohashi T; Yanaga K
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):731-9. PubMed ID: 21484229
[TBL] [Abstract][Full Text] [Related]
20. Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP-1-dependent mechanisms.
Hwang YP; Yun HJ; Kim HG; Han EH; Lee GW; Jeong HG
Biochem Pharmacol; 2010 Jun; 79(12):1714-26. PubMed ID: 20152819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
